Polypharmacy and medication costs at end of life among commercially insured adults age 65 and older with cancer

MLA

Cara L. McDermott, et al. “Polypharmacy and Medication Costs at End of Life among Commercially Insured Adults Age 65 and Older with Cancer.” Journal of Clinical Oncology, vol. 36, Dec. 2018, p. 65. EBSCOhost, https://doi.org/10.1200/jco.2018.36.34_suppl.65.

APA

Cara L. McDermott, Bruce Smith, Gary H. Lyman, J. Randall Curtis, Catherine R. Fedorenko, Karma L. Kreizenbeck, Scott D. Ramsey, Qin Sun, & Ted Conklin. (2018). Polypharmacy and medication costs at end of life among commercially insured adults age 65 and older with cancer. Journal of Clinical Oncology, 36, 65. https://doi.org/10.1200/jco.2018.36.34_suppl.65

Chicago

Cara L. McDermott, Bruce Smith, Gary H. Lyman, J. Randall Curtis, Catherine R. Fedorenko, Karma L. Kreizenbeck, Scott D. Ramsey, Qin Sun, and Ted Conklin. 2018. “Polypharmacy and Medication Costs at End of Life among Commercially Insured Adults Age 65 and Older with Cancer.” Journal of Clinical Oncology 36 (December): 65. doi:10.1200/jco.2018.36.34_suppl.65.